Hikma Pharmaceuticals
HIK.L
#2422
Rank
NZ$10.33 B
Marketcap
$45.62
Share price
-0.20%
Change (1 day)
17.01%
Change (1 year)

EPS for Hikma Pharmaceuticals (HIK.L)

EPS in 2019 (TTM): N/A

In 2022 the company made an earnings per share (EPS) of $1.47 a decrease over its 2021 EPS that were of $3.20.

EPS history for Hikma Pharmaceuticals from 2002 to 2019

Annual EPS

Year EPS Change
2022$1.47-53.98%
2021$3.20-0.16%
2020$3.20-9.06%
2019$3.5271.62%
2018$2.05-133.3%
2017-$6.16-628.27%
2016$1.17-47.47%
2015$2.22-9.83%
2014$2.4630.48%
2013$1.89110.57%
2012$0.9023.73%
2011$0.72-19.65%
2010$0.9025.67%
2009$0.7234.54%
2008$0.53-17.84%
2007$0.6513.5%
2006$0.578.67%
2005$0.53-98.86%
2004$46.1224711.32%
2003$0.1968.25%
2002$0.11